These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator. Weinblatt D; Roy S J Med Cases; 2022 May; 13(5):244-248. PubMed ID: 35655632 [TBL] [Abstract][Full Text] [Related]
5. Liver Injury after Selective Androgen Receptor Modulator Intake: A Case Report and Review of the Literature. Mertens JE; Bömmer MTC; Regier MB; Gabriëls G; Pavenstädt H; Grünewald I; Horvath J; Trebicka J; Schmidt H; Schlevogt B Z Gastroenterol; 2024 Jun; 62(6):935-943. PubMed ID: 37871633 [TBL] [Abstract][Full Text] [Related]
6. Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report. Ladna M; Taylor K; Bhat A; Dideban B J Med Case Rep; 2023 Mar; 17(1):134. PubMed ID: 36978171 [TBL] [Abstract][Full Text] [Related]
7. Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033). Barbara M; Dhingra S; Mindikoglu AL ACG Case Rep J; 2020 Jun; 7(6):e00409. PubMed ID: 33062783 [TBL] [Abstract][Full Text] [Related]
8. Drug-Induced Liver Injury From Enobosarm (Ostarine), a Selective Androgen Receptor Modulator. Bedi H; Hammond C; Sanders D; Yang HM; Yoshida EM ACG Case Rep J; 2021 Jan; 8(1):e00518. PubMed ID: 34368386 [TBL] [Abstract][Full Text] [Related]
9. Mastabol induced acute cholestasis: A case report. Hymel BM; Victor DW; Alvarez L; Shores NJ; Balart LA World J Hepatol; 2013 Mar; 5(3):133-6. PubMed ID: 23556046 [TBL] [Abstract][Full Text] [Related]
10. Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases. Leciejewska N; Jędrejko K; Gómez-Renaud VM; Manríquez-Núñez J; Muszyńska B; Pokrywka A Eur J Clin Pharmacol; 2024 Feb; 80(2):185-202. PubMed ID: 38059982 [TBL] [Abstract][Full Text] [Related]
12. Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review. Koller T; Vrbova P; Meciarova I; Molcan P; Smitka M; Adamcova Selcanova S; Skladany L World J Clin Cases; 2021 Jun; 9(16):4062-4071. PubMed ID: 34141767 [TBL] [Abstract][Full Text] [Related]
13. Bile Cast Nephropathy Because of Acute Liver Injury Associated With Selective Androgen Receptor Modulators. Arayangkool C; Gozun M; Tanariyakul M; Techasatian W; Leesutipornchai T; Nishimura Y ACG Case Rep J; 2023 Jul; 10(7):e01105. PubMed ID: 37501938 [TBL] [Abstract][Full Text] [Related]
14. Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes. Cutler C; Viljanto M; Taylor P; Hincks P; Biddle S; Van Eenoo P Drug Test Anal; 2022 Feb; 14(2):349-370. PubMed ID: 34714606 [TBL] [Abstract][Full Text] [Related]
15. Detection of SARMs in doping control analysis. Thevis M; Schänzer W Mol Cell Endocrinol; 2018 Mar; 464():34-45. PubMed ID: 28137616 [TBL] [Abstract][Full Text] [Related]
16. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review. Machek SB; Cardaci TD; Wilburn DT; Willoughby DS Steroids; 2020 Dec; 164():108753. PubMed ID: 33148520 [TBL] [Abstract][Full Text] [Related]
17. Selective Androgen Receptor Modulator-Induced Liver Injury in Active Duty Male. Lee BK; Park BB; Bower RJ Mil Med; 2022 Mar; ():. PubMed ID: 35253885 [TBL] [Abstract][Full Text] [Related]
18. Clinical and histologic features of Azathioprine-induced hepatotoxicity. Siramolpiwat S; Sakonlaya D Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864 [TBL] [Abstract][Full Text] [Related]